Nozha International Hospital Valuation
Is NINH undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NINH?
Other financial metrics that can be useful for relative valuation.
|What is NINH's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does NINH's PE Ratio compare to its peers?
|Company||PE||Estimated Growth||Market Cap|
AMES Alexandria New Medical Center
CLHO Cleopatra Hospital GroupE
ISPH Ibnsina Pharma
6039 Japan Animal Referral Medical Center
NINH Nozha International Hospital
Price-To-Earnings vs Peers: NINH is good value based on its Price-To-Earnings Ratio (22.2x) compared to the peer average (43.2x).
Price to Earnings Ratio vs Industry
How does NINH's PE Ratio compare vs other companies in the Global Healthcare Industry?
Price to Earnings Ratio vs Fair Ratio
What is NINH's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||22.2x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NINH's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of NINH when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NINH (EGP10.69) is trading above our estimate of fair value (EGP4.22)
Significantly Below Fair Value: NINH is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.